Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: Associated mutations develop motor neuron disease

Journal of Neuroscience

Volumn 21, Issue 23, 2001, Pages 9246-9254

  Nagai, M ^a   Aoki, M ^a   Miyoshi, I ^a   Kato, M ^a   Pasinelli, P ^a   Kasai, N ^a   Brown R H , Jr ^a   Itoyama, Y ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Caspase; Copper zinc SOD; Familial amyotrophic lateral sclerosis; Glutamate; SOD1; Transgenic rats

Indexed keywords

CASPASE; COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; EMBRYO; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; MOTOR NEURON DISEASE; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; SPINAL CORD; TRANSGENE;

EID: 0035575761     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-23-09246.2001     Document Type: Article

References (50)

1. Mild ALS in Japan associated with novel SOD mutation
2. Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: A possible new subtype of familial ALS
3. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels
4. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity
5. Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice
6. The central nervous system in motor neurone disease
7. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusion
8. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: A subtype analysis
9. Oxidation versus aggregation: How do SOD1 mutants cause ALS?
10. From Charcot to SOD1: Mechanisms of selective motor neuron death in ALS
11. Epidemiology of SOD1 mutations in amyotrophic lateral sclerosis
12. Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: Extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation
13. Survival analysis in clinical trials: Past developments and future directions
14. Superoxide dismutases
15. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation
16. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis
17. Stay the executioner's hand
18. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS
19. Plasmids with a kanamycin-resistance gene for site-directed mutagenesis using the oligodeoxyribonucleotide-directed dual amber method
20. Cytopathology in amyotrophic lateral sclerosis
21. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells
22. Successful production of transgenic rats
23. A new bacteriophage P1 -derived vector for the propagation of large human DNA fragments
24. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1
25. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis
26. Ubiquitin deposits in anterior horn cells in motor neurone disease
27. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity
28. Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase
29. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
30. Ubiquitin-positive inclusion in anterior horn cells in subgroups of motor neuron diseases: A comparative study of adult-onset amyotrophic lateral sclerosis, juvenile amyotrophic lateral sclerosis and Werdnig- Hoffmann disease
31. Focal accumulation of phosphorylated neuro-filaments within anterior horn cell in familial amyotrophic lateral sclerosis
32. Familial adult motor neuron disease: Amyotrophic lateral sclerosis
33. Atomic structures of wildtype and thermostable mutant recombinant human Cu, Zn superoxide dismutase
34. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase
35. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis
36. Amyotrophic lateral sclerosis: Amino acid levels in plasma and cerebrospinal fluid
37. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla
38. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
39. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis
40. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
41. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis
42. Glutamate, excitotoxicity and amyotrophic lateral sclerosis
43. Immunohistochemical demonstration of Cu/Zn superoxide dismutase in the spinal cord of patients with familial amyotrophic lateral sclerosis
44. Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis
45. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement
46. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells
47. Localized proton MR spectroscopy of the brain in children
48. Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis
49. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
50. Change in period of free-running rhythms determined by two different tools in blinded rats